JP2008501727A5 - - Google Patents

Download PDF

Info

Publication number
JP2008501727A5
JP2008501727A5 JP2007526135A JP2007526135A JP2008501727A5 JP 2008501727 A5 JP2008501727 A5 JP 2008501727A5 JP 2007526135 A JP2007526135 A JP 2007526135A JP 2007526135 A JP2007526135 A JP 2007526135A JP 2008501727 A5 JP2008501727 A5 JP 2008501727A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
agent according
treatment
photosensitizer
exposure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007526135A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008501727A (ja
Filing date
Publication date
Priority claimed from CA002470403A external-priority patent/CA2470403A1/en
Application filed filed Critical
Priority claimed from PCT/CA2005/000154 external-priority patent/WO2005120572A1/en
Publication of JP2008501727A publication Critical patent/JP2008501727A/ja
Publication of JP2008501727A5 publication Critical patent/JP2008501727A5/ja
Pending legal-status Critical Current

Links

JP2007526135A 2004-06-09 2005-02-08 外用塗布した疎水性緑色ポルフィリンを用いた機能亢進性皮脂腺障害を治療するための光線力学的療法 Pending JP2008501727A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002470403A CA2470403A1 (en) 2004-02-06 2004-06-09 Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders
PCT/CA2005/000154 WO2005120572A1 (en) 2004-06-09 2005-02-08 Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins

Publications (2)

Publication Number Publication Date
JP2008501727A JP2008501727A (ja) 2008-01-24
JP2008501727A5 true JP2008501727A5 (https=) 2008-03-27

Family

ID=37649609

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007526135A Pending JP2008501727A (ja) 2004-06-09 2005-02-08 外用塗布した疎水性緑色ポルフィリンを用いた機能亢進性皮脂腺障害を治療するための光線力学的療法

Country Status (11)

Country Link
EP (1) EP1755676B1 (https=)
JP (1) JP2008501727A (https=)
AU (1) AU2005251395A1 (https=)
BR (1) BRPI0511897A (https=)
CA (1) CA2568744A1 (https=)
DK (1) DK1755676T3 (https=)
ES (1) ES2400566T3 (https=)
MX (1) MX2007000338A (https=)
NZ (1) NZ551636A (https=)
WO (1) WO2005120572A1 (https=)
ZA (1) ZA200610239B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2454974T3 (es) 2007-06-27 2014-04-14 The General Hospital Corporation Aparato para la inhibición óptica de la terapia fotodinámica
AU2008337067A1 (en) * 2007-12-14 2009-06-25 Photoderma Sa Novel compounds useful in therapeutic and cosmetic methods
WO2009093144A2 (en) * 2008-01-25 2009-07-30 Qlt, Inc.Lau Photodynamic therapy of sebaceous gland disorders
FR2927800A1 (fr) * 2008-02-25 2009-08-28 Oreal Association d'un rayonnement lumineux et d'un compose bioconvertible par la lipase pour ameliorer l'apparence de la peau et/ou du cheveu.
JP5808107B2 (ja) 2008-12-17 2015-11-10 学校法人慶應義塾 細胞特異的能動集積性を有する光線力学療法剤
BR112013017953A2 (pt) * 2011-01-13 2017-08-29 Quadra Logic Tech Inc Composição farmacêutica, formulação tópica, método, e, composição fotossensibilizadora
EP2794004B1 (en) * 2011-12-19 2020-07-29 Photocure ASA Irradiation apparatus
HU230989B1 (hu) * 2013-01-17 2019-08-28 Gd Photonics Kft. Készítmény az UVB-fényterápia hatékonyságának fokozására, eljárás annak előállítására és alkalmazása
JP6595484B2 (ja) * 2013-12-20 2019-10-23 ガルデルマ・リサーチ・アンド・デヴェロップメント 光損傷皮膚のパルス光力学的処置
ES2860807T3 (es) 2015-10-15 2021-10-05 Dusa Pharmaceuticals Inc Iluminador ajustable para terapia y diagnóstico fotodinámicos
US10603508B2 (en) 2015-10-15 2020-03-31 Dusa Pharmaceuticals, Inc. Adjustable illuminators and methods for photodynamic therapy and diagnosis
US11331304B2 (en) 2016-05-11 2022-05-17 The Jackson Laboratory YAP1 inhibitors and methods
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy
EP3989960A4 (en) * 2019-06-25 2023-06-28 Dusa Pharmaceuticals, Inc. Methods for reducing pain during photodynamic therapy of actinic keratosis
FR3109086B1 (fr) 2020-04-14 2025-10-24 Ifremer utilisation d’un extrait polaire de Skeletonema dans une thérapie photodynamique
AU2024295226A1 (en) 2023-07-07 2026-02-12 Fermentalg Red algae biomass extract, and cosmetic use thereof for eliminating skin imperfections

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171749A (en) 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
GB8805849D0 (en) 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
US5955490A (en) 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US6492420B2 (en) * 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
IL116126A0 (en) 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them
US6004821A (en) 1998-03-07 1999-12-21 Levine; Robert A. Method and apparatus for performing chemical, qualitative, quantitative, and semi-quantitative analyses of a urine sample
AU4645099A (en) 1998-07-09 2000-02-01 Yoram Harth Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea
US6887260B1 (en) * 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US6183773B1 (en) * 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
IL133253A0 (en) 1999-12-01 2001-04-30 Yeda Res & Dev Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
GB0005855D0 (en) 2000-03-10 2000-05-03 Scotia Holdings Plc Compounds for pdt
GB2360459B (en) 2000-03-23 2002-08-07 Photo Therapeutics Ltd Therapeutic light source and method
GB2361430A (en) 2000-04-17 2001-10-24 Photo Therapeutics Ltd Therapeutic discharge lamps
EP2269645A3 (en) 2000-08-16 2011-01-12 The General Hospital Corporation doing business as Massachusetts General Hospital Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
US7018396B2 (en) * 2001-08-07 2006-03-28 New England Medical Center Hospitals, Inc. Method of treating acne
CA2466425A1 (en) 2001-11-09 2003-05-15 Qlt Inc. Photodynamic therapy for the treatment of hair loss
AU2003230808A1 (en) 2002-04-05 2003-10-27 Candela Corporation High fluence rate activation of photosensitizers for dermatological applications
CA2457214A1 (en) * 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne

Similar Documents

Publication Publication Date Title
JP2008501727A5 (https=)
Bonnet Why develop photoactivated chemotherapy?
Aebisher et al. The use of photodynamic therapy in medical practice
Wachowska et al. Aminolevulinic acid (ALA) as a prodrug in photodynamic therapy of cancer
Ashur et al. Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin
Konopka et al. Photodynamic therapy in dentistry
Brown et al. The present and future role of photodynamic therapy in cancer treatment
Sharma et al. Photodynamic therapy for cancer and for infections: what is the difference?
Gold et al. 5‐aminolevulinic acid photodynamic therapy: where we have been and where we are going
Babilas et al. Photodynamic therapy in dermatology: state‐of‐the‐art
Messmann et al. Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies
Calzavara‐Pinton et al. Photodynamic therapy: update 2006 Part 2: Clinical results
JP2007522137A5 (https=)
US20190209686A1 (en) Pulse photodynamic treatment of acne
Hong et al. Topical aminolevulinic acid‐photodynamic therapy for the treatment of acne vulgaris
PT1814534E (pt) Derivados do ácido 5-aminolevulínico para o tratamento do acne
Abdel-Kader History of photodynamic therapy
Domka et al. Photodynamic therapy in brain cancer: mechanisms, clinical and preclinical studies and therapeutic challenges
Baldea et al. Photodynamic therapy of melanoma using new, synthetic porphyrins and phthalocyanines as photosensitisers–a comparative study
Na et al. Indole‐3‐acetic acid: a potential new photosensitizer for photodynamic therapy of acne vulgaris
US8180444B2 (en) Enhanced PhotoDynamic Therapy with immune system assist
Buggiani et al. Photodynamic therapy: off-label and alternative use in dermatological practice
ES2778031T3 (es) Método para el tratamiento del acné
Bai et al. The relationship of phthalocyanine 4 (pc 4) concentrations measured noninvasively to outcome of pc 4 photodynamic therapy in mice
RU2007123165A (ru) Способ лечения инфекционных кератитов